Home > Balance Sheet > BLISS GVS PHARMA

BLISS GVS PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
BLISS GVS PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

BLISS GVS PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹37 Cr₹51 Cr₹43 Cr₹29 Cr₹45 Cr

What is the latest Total Non-Current Liabilities ratio of BLISS GVS PHARMA ?

The latest Total Non-Current Liabilities ratio of BLISS GVS PHARMA is ₹37 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹37 Cr
Mar2024₹51 Cr
Mar2023₹43 Cr
Mar2022₹29 Cr
Mar2021₹45 Cr

How is Total Non-Current Liabilities of BLISS GVS PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹37 Cr
-27.20
Mar2024 ₹51 Cr
19.52
Mar2023 ₹43 Cr
46.71
Mar2022 ₹29 Cr
-35.46
Mar2021 ₹45 Cr -

Compare Total Non-Current Liabilities of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹2,362.0 Cr 0.6% 44.1% 71.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

0.6%

44.1%

71.3%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses